Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/aje/kwad004 | DOI Listing |
Nutr J
January 2025
École de nutrition, Faculté des sciences de l'agriculture et de l'alimentation (FSAA), Université Laval, 2440, boulevard Hochelaga, Québec, Québec, G1V 0A6, Canada.
Background: A better understanding of correlates of sugary drink consumption is essential to inform public health interventions. This study examined differences in perceived healthiness of sugary drinks and related social norms between countries, over time, and sociodemographic groups and associations with sugary drink intake.
Methods: This study used annual cross-sectional data from the International Food Policy Study from 2018 to 2021 in Australia, Canada, the United Kingdom, the United States, and Mexico.
PLoS One
January 2025
Instituto René Rachou, Fiocruz Minas, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Minas Gerais, Brazil.
Background: To develop an effective vaccine against Plasmodium vivax, the most widely dispersed human malaria parasite, it is critical to understand how coinfections with other pathogens could impact malaria-specific immune response. A recent conceptual study proposed that Epstein-Barr virus (EBV), a highly prevalent human herpesvirus that establishes lifelong persistent infection, may influence P. vivax antibody responses.
View Article and Find Full Text PDFmedRxiv
January 2025
Johns Hopkins University School of Medicine, Department of Orthopaedic Surgery, 601 N Caroline Street, Suite 5244, Baltimore MD 21287.
Objective: To examine physical therapists' experience providing telerehabilitation and their perceptions of telerehabilitation for patients with musculoskeletal conditions.
Methods: Survey of members of the Academy of Orthopaedic Physical Therapy.
Results: We received 208 completed responses to our survey invitation.
BMJ Open
January 2025
Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Introduction: Despite repeated vaccinations against SARS-CoV-2 virus, patients who are immunocompromised remain at very high risk of catching SARS-CoV-2 virus and becoming unwell. AZD7442 (Evusheld) is a long-acting monoclonal antibody treatment that has been shown in clinical trials to prevent SARS-CoV-2 infection for up to a year after a single dose. Vaccines require a healthy immune system to generate protective immunity.
View Article and Find Full Text PDFBMJ Paediatr Open
January 2025
Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria
Introduction: The current study aims to give an overview of transition-to-home services provided by perinatal centres in Austria and Switzerland and to evaluate parental satisfaction with the care provided.
Methods: This cross-sectional multicentred study was conducted by performing two surveys between May 2022 and November 2023: one among all level III perinatal centres in Austria (n=7) and Switzerland (n=9) (institutional survey) and one among parents of very preterm infants treated at one selected perinatal centre in each of the two countries (parental survey). Both questionnaires consisted of matching questions focusing on current transition-to-home services.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!